Evidence map›Paper›PMID 33374288›Full record

ArticleInternational journal of molecular sciences2020

S-Adenosyl-l-Methionine Overcomes uL3-Mediated Drug Resistance in p53 Deleted Colon Cancer Cells.

Laura Mosca, Martina Pagano, Annalisa Pecoraro, Luigi Borzacchiello, Luigi Mele, Giovanna Cacciapuoti, Marina Porcelli, Giulia Russo, Annapina Russo

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Antiproliferative Effects of the Aptamer d(GGGT)International journal of molecular sciences · 2022
    Article
  17. Dichloromethane fractions ofMolecular medicine reports · 2022
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Laura MoscaDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", Via Luigi De Crecchio, 80138 Naples, Italy.
Martina PaganoDepartment of Pharmacy, University of Naples "Federico II", Via Domenico Montesano 49, 80131 Naples, Italy.
Annalisa PecoraroDepartment of Pharmacy, University of Naples "Federico II", Via Domenico Montesano 49, 80131 Naples, Italy.
Luigi BorzacchielloDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", Via Luigi De Crecchio, 80138 Naples, Italy.
Luigi MeleDepartment of Experimental Medicine, University of Campania "Luigi Vanvitelli", Via Luciano Armanni, 5, 80138 Naples, Italy.
Giovanna CacciapuotiDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", Via Luigi De Crecchio, 80138 Naples, Italy.
Marina PorcelliDepartment of Precision Medicine, University of Campania "Luigi Vanvitelli", Via Luigi De Crecchio, 80138 Naples, Italy.ORCID 0000-0003-0192-1728
Giulia RussoDepartment of Pharmacy, University of Naples "Federico II", Via Domenico Montesano 49, 80131 Naples, Italy.
Annapina RussoDepartment of Pharmacy, University of Naples "Federico II", Via Domenico Montesano 49, 80131 Naples, Italy.ORCID 0000-0002-7509-3702
University of Campania "Luigi Vanvitelli" · ITUniversity of Naples Federico II · IT

Funding

Intradepartmental Projects, Department of Precision Medicine Università della Campania "Luigi Vanvitelli".MIUR Fondo di ricerca di base FFABR-2017Programme Valere 2020 Vanvitelli per la Ricerca; Università della Campania "Luigi VanvitelliRegione Campania-POR Campania FESR 2014/2020 " Project N. B61G18000470007
6 · The paper itself

Abstract

purposeIn order to study novel therapeutic approaches taking advantage of natural compounds showing anticancer and anti-proliferative effects, we focused our interest on S-adenosyl-l-methionine, a naturally occurring sulfur-containing nucleoside synthesized from adenosine triphosphate and methionine by methionine adenosyltransferase, and its potential in overcoming drug resistance in colon cancer cells devoid of p53.

resultsIn the present study, we demonstrated that S-adenosyl-l-methionine overcomes uL3-mediated drug resistance in p53 deleted colon cancer cells. In particular, we demonstrated that S-adenosyl-l-methionine causes cell cycle arrest at the S phase; inhibits autophagy; augments reactive oxygen species; and induces apoptosis in these cancer cells.

conclusionsResults reported in this paper led us to propose S-adenosyl-l-methionine as a potential promising agent for cancer therapy by examining p53 and uL3 profiles in tumors to yield a better clinical outcomes.

Indexed as

Colonic NeoplasmsGene DeletionDrug Resistance, NeoplasmHCT116 CellsHumansRibosomal Protein L3Ribosomal ProteinsS-AdenosylmethionineTumor Suppressor Protein p53Ribosomal Protein L3Ribosomal ProteinsRPL3 protein, humanS-AdenosylmethionineTP53 protein, humanTumor Suppressor Protein p53AdoMetapoptosisautophagycolon cancerdrug resistanceuL3

Identifiers

PMID33374288
PMCPMC7795960
OpenAlexW3113968855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.